BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30617870)

  • 1. Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer.
    Uno Y; Kanda M; Miwa T; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2019 Mar; 26(3):836-844. PubMed ID: 30617870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNAJC12 promotes lung cancer growth by regulating the activation of β‑catenin.
    Li Y; Li M; Jin F; Liu J; Chen M; Yin J
    Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33907820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homeobox C10 Influences on the Malignant Phenotype of Gastric Cancer Cell Lines and its Elevated Expression Positively Correlates with Recurrence and Poor Survival.
    Miwa T; Kanda M; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hayashi M; Yamada S; Nakayama G; Koike M; Kodera Y
    Ann Surg Oncol; 2019 May; 26(5):1535-1543. PubMed ID: 30673899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of DNAJC12 predicts poor response to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer.
    He HL; Lee YE; Chen HP; Hsing CH; Chang IW; Shiue YL; Lee SW; Hsu CT; Lin LC; Wu TF; Li CF
    Exp Mol Pathol; 2015 Jun; 98(3):338-45. PubMed ID: 25805104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBXO50 Enhances the Malignant Behavior of Gastric Cancer Cells.
    Miwa T; Kanda M; Tanaka H; Tanaka C; Kobayashi D; Umeda S; Iwata N; Hayashi M; Yamada S; Fujii T; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2017 Nov; 24(12):3771-3779. PubMed ID: 28560594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer.
    Hu Q; Masuda T; Sato K; Tobo T; Nambara S; Kidogami S; Hayashi N; Kuroda Y; Ito S; Eguchi H; Saeki H; Oki E; Maehara Y; Mimori K
    Ann Surg Oncol; 2018 Mar; 25(3):745-753. PubMed ID: 29270876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer.
    Sawaki K; Kanda M; Miwa T; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2018 Jul; 25(7):2083-2090. PubMed ID: 29663169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of calreticulin as a prognosis marker and angiogenic regulator in human gastric cancer.
    Chen CN; Chang CC; Su TE; Hsu WM; Jeng YM; Ho MC; Hsieh FJ; Lee PH; Kuo ML; Lee H; Chang KJ
    Ann Surg Oncol; 2009 Feb; 16(2):524-33. PubMed ID: 19050968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas.
    Zheng HC; Xu XY; Xia P; Yu M; Takahashi H; Takano Y
    Hum Pathol; 2010 Sep; 41(9):1255-64. PubMed ID: 20447678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
    Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
    Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-3196 acts as a Tumor Suppressor and Predicts Survival Outcomes in Patients With Gastric Cancer.
    Chen G; Wan J; Wang Z; Li L; Jia H; Xing S; Chen S; Fan X; Li R
    Technol Cancer Res Treat; 2020; 19():1533033820923427. PubMed ID: 32419651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.
    Kanda M; Shimizu D; Tanaka H; Shibata M; Iwata N; Hayashi M; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncotarget; 2016 Mar; 7(12):13667-79. PubMed ID: 26872374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation miR-539 is associated with poor prognosis of gastric cancer patients and aggressive progression of gastric cancer cells.
    Jin W; Han H; Liu D
    Cancer Biomark; 2019; 26(2):183-191. PubMed ID: 31403943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of HDAC7 in cancerous gastric tissues is positively associated with distant metastasis and poor patient prognosis.
    Yu Y; Cao F; Yu X; Zhou P; Di Q; Lei J; Tai Y; Wu H; Li X; Wang X; Zhang W; Li P; Li Y
    Clin Transl Oncol; 2017 Aug; 19(8):1045-1054. PubMed ID: 28299580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
    He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
    World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STRA6 Expression Serves as a Prognostic Biomarker of Gastric Cancer.
    Nakamura S; Kanda M; Shimizu D; Sawaki K; Tanaka C; Hattori N; Hayashi M; Yamada S; Nakayama G; Omae K; Koike M; Kodera Y
    Cancer Genomics Proteomics; 2020; 17(5):509-516. PubMed ID: 32859629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of NUAK1 is associated with disease-free survival and overall survival in patients with gastric cancer.
    Ye XT; Guo AJ; Yin PF; Cao XD; Chang JC
    Med Oncol; 2014 Jul; 31(7):61. PubMed ID: 24943992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Discovery and verification of matrix gla protein, a TNM staging and prognosis-related biomarker for gastric cancer].
    Guo L; Guo XB; Jiang JL; Zhang JN; Ji J; Liu BY; Zhu ZG; Yu YY
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):436-41. PubMed ID: 21055170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.